{"id":{"repo_id":"mcmaster","oai_identifier":"oai:macsphere.mcmaster.ca:11375/32286"},"canonical_url":"https://search.ndltd.org/etd/mcmaster/oai:macsphere.mcmaster.ca:11375/32286","repository":{"repo_id":"mcmaster","name":"McMaster University","base_url":"https://macsphere.mcmaster.ca/server/oai/request"},"display":{"title":"Effectiveness and tolerability of perioperative interventions to prevent chronic pain after knee or hip replacement surgery: A systematic review with network and component network meta-analysis of randomized controlled trials","abstract":"Background: Chronic pain is a common complication after musculoskeletal and orthopedic surgeries. We conducted a systematic review with network and component network meta-analysis of randomized trials to assess the effectiveness and tolerability of perioperative pharmacological interventions for preventing chronic pain after knee or hip replacement surgery. Methods: We searched MEDLINE, Embase, PsycInfo, CINAHL, and CENTRAL to February 2025. Eligible trials enrolled adults undergoing knee or hip replacement, randomized them to any pharmacotherapy, combination, or placebo to reduce post-surgical pain, and assessed pain ≥3 months post-surgery. Outcomes included the proportion of patients reporting chronic post-surgical pain (CPSP), pain severity, physical and emotional functioning, and drop out rates. Analyses used frequentist random-effects models for network and an additive component network meta-analysis (CNMA). We assessed the certainty evidence following GRADE guidance using CINeMA platform. Findings: We included 59 trials (7,705 patients). At 3–6 months, epidural corticosteroid injection may reduce CPSP compared to usual care (risk ratio [RR] 0.35, 95% CI 0.14–0.90; risk difference 11.7% fewer patients, low certainty). At 6–12 months, wound infiltration of corticosteroids probably had little to no effect on pain intensity (mean difference [MD] −0.31, 95% CI −0.57 to −0.05, moderate certainty). At longest follow-up, ketamine may slightly improve physical function (MD 10.77, 95% CI 5.21–16.33, low certainty). Other interventions showed little to no effect on pain or functioning. CNMA indicated corticosteroids reduced CPSP risk (incremental RR 0.58, 95% CI 0.39–0.86). Benefits were primarily observed in knee replacement surgeries. None of the interventions influenced dropout or tolerability. Conclusions: Low to moderate certainty evidence suggests epidural corticosteroid injection may reduce CPSP after knee/hip replacement, while most pharmacotherapies show minimal benefit. CNMA found the steroid component reduced CPSP risk; ketamine, nefopam, and steroids each improved physical function. Future research should prioritize large, randomized trials and identification of modifiable predictors of CPSP.","abstract_html":"Background: Chronic pain is a common complication after musculoskeletal and orthopedic surgeries. We conducted a systematic review with network and component network meta-analysis of randomized trials to assess the effectiveness and tolerability of perioperative pharmacological interventions for preventing chronic pain after knee or hip replacement surgery. Methods: We searched MEDLINE, Embase, PsycInfo, CINAHL, and CENTRAL to February 2025. Eligible trials enrolled adults undergoing knee or hip replacement, randomized them to any pharmacotherapy, combination, or placebo to reduce post-surgical pain, and assessed pain ≥3 months post-surgery. Outcomes included the proportion of patients reporting chronic post-surgical pain (CPSP), pain severity, physical and emotional functioning, and drop out rates. Analyses used frequentist random-effects models for network and an additive component network meta-analysis (CNMA). We assessed the certainty evidence following GRADE guidance using CINeMA platform. Findings: We included 59 trials (7,705 patients). At 3–6 months, epidural corticosteroid injection may reduce CPSP compared to usual care (risk ratio [RR] 0.35, 95% CI 0.14–0.90; risk difference 11.7% fewer patients, low certainty). At 6–12 months, wound infiltration of corticosteroids probably had little to no effect on pain intensity (mean difference [MD] −0.31, 95% CI −0.57 to −0.05, moderate certainty). At longest follow-up, ketamine may slightly improve physical function (MD 10.77, 95% CI 5.21–16.33, low certainty). Other interventions showed little to no effect on pain or functioning. CNMA indicated corticosteroids reduced CPSP risk (incremental RR 0.58, 95% CI 0.39–0.86). Benefits were primarily observed in knee replacement surgeries. None of the interventions influenced dropout or tolerability. Conclusions: Low to moderate certainty evidence suggests epidural corticosteroid injection may reduce CPSP after knee/hip replacement, while most pharmacotherapies show minimal benefit. CNMA found the steroid component reduced CPSP risk; ketamine, nefopam, and steroids each improved physical function. Future research should prioritize large, randomized trials and identification of modifiable predictors of CPSP.","abstract_has_math":false,"creators":["Khosravirad, Azin"],"institution":null,"degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":"Health Research Methodology","school":null,"contributors":[],"advisors":["Sadeghirad, Behnam"],"committee_chairs":[],"committee_members":[],"year":2025,"date_issued":"2025","date_published":"2025","updated_at":"2026-11-18T19:30:48Z","subjects":[],"languages":["en_US"],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://doi.org/10.71548/8516"],"render_values":[{"text":"https://doi.org/10.71548/8516","href":"https://doi.org/10.71548/8516","code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"http://hdl.handle.net/11375/32286","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"http://hdl.handle.net/11375/32286","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://macsphere.mcmaster.ca/server/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Amacsphere.mcmaster.ca%3A11375%2F32286","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Sadeghirad, Behnam"]},{"key":"dc:contributor.department","label":"Department","values":["Health Research Methodology"]},{"key":"dc:creator","label":"Author","values":["Khosravirad, Azin"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2025-09-09T15:18:10Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2025-09-09T15:18:10Z"]},{"key":"dc:date.issued","label":"Date","values":["2025"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en_US"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://hdl.handle.net/11375/32286","https://doi.org/10.71548/8516"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Background: Chronic pain is a common complication after musculoskeletal and orthopedic surgeries. We conducted a systematic review with network and component network meta-analysis of randomized trials to assess the effectiveness and tolerability of perioperative pharmacological interventions for preventing chronic pain after knee or hip replacement surgery. Methods: We searched MEDLINE, Embase, PsycInfo, CINAHL, and CENTRAL to February 2025. Eligible trials enrolled adults undergoing knee or hip replacement, randomized them to any pharmacotherapy, combination, or placebo to reduce post-surgical pain, and assessed pain ≥3 months post-surgery. Outcomes included the proportion of patients reporting chronic post-surgical pain (CPSP), pain severity, physical and emotional functioning, and drop out rates. Analyses used frequentist random-effects models for network and an additive component network meta-analysis (CNMA). We assessed the certainty evidence following GRADE guidance using CINeMA platform. Findings: We included 59 trials (7,705 patients). At 3–6 months, epidural corticosteroid injection may reduce CPSP compared to usual care (risk ratio [RR] 0.35, 95% CI 0.14–0.90; risk difference 11.7% fewer patients, low certainty). At 6–12 months, wound infiltration of corticosteroids probably had little to no effect on pain intensity (mean difference [MD] −0.31, 95% CI −0.57 to −0.05, moderate certainty). At longest follow-up, ketamine may slightly improve physical function (MD 10.77, 95% CI 5.21–16.33, low certainty). Other interventions showed little to no effect on pain or functioning. CNMA indicated corticosteroids reduced CPSP risk (incremental RR 0.58, 95% CI 0.39–0.86). Benefits were primarily observed in knee replacement surgeries. None of the interventions influenced dropout or tolerability. Conclusions: Low to moderate certainty evidence suggests epidural corticosteroid injection may reduce CPSP after knee/hip replacement, while most pharmacotherapies show minimal benefit. CNMA found the steroid component reduced CPSP risk; ketamine, nefopam, and steroids each improved physical function. Future research should prioritize large, randomized trials and identification of modifiable predictors of CPSP."]},{"key":"dc:description.degree","label":"Dc Description Degree","values":["Master of Science (MSc)"]},{"key":"dc:title","label":"Title","values":["Effectiveness and tolerability of perioperative interventions to prevent chronic pain after knee or hip replacement surgery: A systematic review with network and component network meta-analysis of randomized controlled trials"]},{"key":"others:access_status","label":"Others Access Status","values":["open.access"]}]}],"canonical_facts":{"dc:contributor.advisor":["Sadeghirad, Behnam"],"dc:contributor.department":["Health Research Methodology"],"dc:creator":["Khosravirad, Azin"],"dc:date.accessioned":["2025-09-09T15:18:10Z"],"dc:date.available":["2025-09-09T15:18:10Z"],"dc:date.issued":["2025"],"dc:description.abstract":["Background: Chronic pain is a common complication after musculoskeletal and orthopedic surgeries. We conducted a systematic review with network and component network meta-analysis of randomized trials to assess the effectiveness and tolerability of perioperative pharmacological interventions for preventing chronic pain after knee or hip replacement surgery. Methods: We searched MEDLINE, Embase, PsycInfo, CINAHL, and CENTRAL to February 2025. Eligible trials enrolled adults undergoing knee or hip replacement, randomized them to any pharmacotherapy, combination, or placebo to reduce post-surgical pain, and assessed pain ≥3 months post-surgery. Outcomes included the proportion of patients reporting chronic post-surgical pain (CPSP), pain severity, physical and emotional functioning, and drop out rates. Analyses used frequentist random-effects models for network and an additive component network meta-analysis (CNMA). We assessed the certainty evidence following GRADE guidance using CINeMA platform. Findings: We included 59 trials (7,705 patients). At 3–6 months, epidural corticosteroid injection may reduce CPSP compared to usual care (risk ratio [RR] 0.35, 95% CI 0.14–0.90; risk difference 11.7% fewer patients, low certainty). At 6–12 months, wound infiltration of corticosteroids probably had little to no effect on pain intensity (mean difference [MD] −0.31, 95% CI −0.57 to −0.05, moderate certainty). At longest follow-up, ketamine may slightly improve physical function (MD 10.77, 95% CI 5.21–16.33, low certainty). Other interventions showed little to no effect on pain or functioning. CNMA indicated corticosteroids reduced CPSP risk (incremental RR 0.58, 95% CI 0.39–0.86). Benefits were primarily observed in knee replacement surgeries. None of the interventions influenced dropout or tolerability. Conclusions: Low to moderate certainty evidence suggests epidural corticosteroid injection may reduce CPSP after knee/hip replacement, while most pharmacotherapies show minimal benefit. CNMA found the steroid component reduced CPSP risk; ketamine, nefopam, and steroids each improved physical function. Future research should prioritize large, randomized trials and identification of modifiable predictors of CPSP."],"dc:description.degree":["Master of Science (MSc)"],"dc:identifier.uri":["http://hdl.handle.net/11375/32286","https://doi.org/10.71548/8516"],"dc:language.iso":["en_US"],"dc:title":["Effectiveness and tolerability of perioperative interventions to prevent chronic pain after knee or hip replacement surgery: A systematic review with network and component network meta-analysis of randomized controlled trials"],"dc:type":["Thesis"],"others:access_status":["open.access"]},"updated_at":"2026-11-18T19:30:48Z"}